Celldex Therapeutics Inc (CLDX)

EBITDA Margin

-330004.55%

Quarterly · Period ending:

CLDX logo

CLDX EBITDA Margin

Latest reported-330004.55%
CLDX Quarterly EBITDA Margin (100.00% → -330004.55%)
High-resolution chart · PNG

CLDX ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Celldex Therapeutics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-330,004.5455%
-518,873.3333%
-107,392%
0%
-7,633.8356%
-7,615.6835%
-3,938.1277%
-1,295.362%
-1,402.9223%
-20,533.9744%
-831.9535%
-2,471.5227%
-11,099.2537%
-2,961.2203%
-1,600.372%
-6,415.9705%
-16,552.7607%
-13,208.046%
-5,930.5389%
-12,073.8562%
-356.8391%
-2,245.4013%
-251.2021%
-1,919.012%
-5,020.7627%
-420.3812%
-1,299.4363%
-2,335.1648%
-1,695.2448%
-931.2281%
-740.0227%
-1,473.3262%
-843.7568%
-549.9508%
-719.9074%
-568.6035%
-697.3884%
-1,963.6245%
-1,566.4354%
-1,308.0631%
-2,262.059%
-2,663.7759%
-1,806.648%
-3,055.653%
-1,459.3205%
-6,184.3621%
-2,110.5619%
-2,678.1108%
-4,681.25%
-6,768.5096%
-3,443.7097%
-2,299.6939%
-18,483.5052%
-690.9693%
-433.9183%
-449.5663%
-624.2409%
-503.4114%
-455.7929%
-427.9306%
-462.2439%
-342.3291%
72.6068%
-324.5847%
-268.6547%
-187.9612%
-246.0596%
-159.8511%
-297.095%
-187.7187%
-238.6423%
-329.2656%
-486.7231%
-4,761.9425%
-270.9972%
-1,292.2595%
-179.574%
-337.8463%
-1,691.102%
-1,652.6968%
-1,154.1821%
-64.9249%
-575.9917%
-482.999%
-677.506%
-481.9193%
-138.9108%
-644.7441%
-400.7683%
-50.8713%
-313.8277%
-85.2414%
-254.1358%
-447.2935%
-394.1169%
-0.0132%
-766.3037%
-678.5063%
-697.4244%
-832.4604%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.